Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2021-11-15 Capital/Financing Update
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Capital/Financing Update Classification · 95% confidence The document is a short notice informing the stock exchanges about the schedule of an analyst/institutional investor meeting, specifically a conference call. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The document does not contain any financial data, detailed financial results, or report content. It is an announcement of a meeting rather than a report or transcript. Therefore, it fits best under the category of Capital/Financing Update (CAP), which includes updates on investor meetings and related activities.
2021-11-15 English
Acquisition
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no textual content or substantive information. The true document length is only 171 characters, indicating it is extremely short and contains no report or announcement details. There is no indication of any report, announcement, or filing type. Given the lack of content, the document cannot be classified as a substantive report or announcement. According to the rules, such minimal content with no text defaults to Regulatory Filings (RNS) as a fallback category.
2021-11-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the schedule of an analyst/institutional investor meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an intimation or announcement rather than a detailed report or transcript. It does not contain financial data, management discussion, or detailed presentation materials. It is not a transcript of the meeting, nor a report or earnings release. Given the short length (1236 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement and a fallback category for miscellaneous filings that do not fit other categories.
2021-11-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-11-09 English
Copy of Newspaper Publication
Regulatory Filings
2021-11-02 English
ESOP/ESOS/ESPS
Remuneration Information Classification · 95% confidence The document text primarily discusses details about stock options granted by the Nomination & Remuneration Committee, including number of options, pricing, vesting conditions, and exercise terms. It references SEBI (SBEB) Regulations, 2014, indicating compliance with regulatory requirements for stock option schemes. There is no indication of this being a full financial report, earnings release, or management discussion. The content is focused on remuneration-related stock option grants, which aligns with disclosures about executive compensation and stock option plans. Given the focus on remuneration and stock options, the document fits best under Remuneration Information (DEF 14A) category, which covers reports detailing compensation for top executives and directors, including stock option grants. The document length is short and does not contain financial statements or broader company performance data, so it is not an Annual Report or Interim Report. Therefore, the classification is DEF 14A with high confidence.
2021-11-01 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.